pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ
Jazz Pharmaceuticals Ireland
Jazz Pharmaceuticals Ireland Limited
Jazz Pharmaceuticals Ireland is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker JAZZ. Primary therapeutic focus areas include Acute Myeloid Leukemia, Narcolepsy, Epilepsy, Acute Lymphobl
Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waterloo Exchange, Waterloo Road, Dublin, 4, IE
- Founded
- 2003
- Employees
- 3,631
- Programs
- 208
- Drugs
- 91
- Patents
- 89
Enasidenib Mesylate
Phase 2 · small molecule · Recurrent Acute Myeloid Leukemia
Enasidenib Mesylate for Recurrent Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code 18-001416
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Jazz Pharmaceuticals Ireland Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Recurrent Acute Myeloid Leukemia
- Status
- active
- Trials
- 1